Similar to IM7, KM81 has been shown to reduce the number of granulocytes circulating in the periphery [14], providing further support for the concept that CD44 antibodies may be treating arthritis by a mechanism that does not rely solely on platelet depletion. The gene discussed is CD44; the disease is arthritic joint disease.